Chronic exposure to high glucose impairs multiple β-cell functions in cultured human pancreatic islets

Current Opinion in Endocrinology and Diabetes

Volumn 7, Issue 1, 2000, Pages 44-48

  Melloul, Danielle ^a   Kaiser, Nurit ^a   Cerasi, Erol ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; GLUCOSE; INSULIN; MESSENGER RNA; PROINSULIN; TRANSCRIPTION FACTOR;

ARTICLE; CELL CULTURE; CELL FUNCTION; CYTOTOXICITY; DNA BINDING; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPOINSULINEMIA; INSULIN RELEASE; INSULIN RESPONSE; PANCREAS ISLET BETA CELL;

EID: 0034050838     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-200002000-00007     Document Type: Article

References (34)

1. 1 Seaquist ER, Kahn SE, Clark PM, Hales CN, Porte D Jr, Robertson RP: Hyperproinsulinemia is associated with increased β-cell demand after hemipancreatectomy in humans. J Clin Invest 1996, 97:455-460.
2. 2 Alarcon C, Leahy JL, Schuppin GT, Rhodes CJ: Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperinsulinemia in a glucose-infusion rat model of non-insulin-dependent diabetes mellitus. J Clin Invest 1995, 95:1032-1039.
3. 3 Gadot M, Ariav Y, Cerasi E, Kaiser N, Gross D: Hyperproinsulinemia in the diabetic Psammomys obesus is a result of increased secretory demand on the B-cell. Endocrinology 1995, 136:4218-4223.
4. 4 Hostens K, Ling Z, Van Schravendijk C, Pipeleers D: Prolonged exposure of human beta-cells to high glucose increases their release of proinsulin during acute stimulation with glucose or arginine. J Clin Endocrinol Metab 1999, 84:1386-1390. Human islets cultured at 20 mM glucose for 10 to 13 days lost the intracellular hormone stores and increased the proinsulin fraction; β-cells were hyperstimulated, since the response to arginine was exaggerated.
5. 5 Bertuzzi F, Saccomanno K, Socci C, Davalli AM, Taglietti MV, Berra C, et al.: Long-term in vitro exposure to high glucose increases proinsulin-like-molecules released by isolated human islets. J Endocrinol 1998, 158:205-211.
6. 6 Lupi R, Del Guerra S, Tellini C, Giannareli R, Coppelli A, Lorenzetti M, et al.: The biguanide compound metformin prevents desensitization of human pancreatic islets induced by high glucose. Eur J Pharmacol 1999, 364:205-209. Addition of metformin, but not glyburide, to human islets cultured for 24 hours at 22 mM glucose prevented the impairment of the acute insulin release.
7. 7 Björklund A, Grill V: Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets. Diabetes 1999, 48:1409-1414. This article provides experimental evidence indicating that the increased proinsulin-to-insulin ratio under conditions of in vitro long-term stimulation of human islets is secondary to depletion of islet insulin stores, since this is preventable by diazoxide.
8. 8 Marshak S, Leibowitz G, Bertuzzi F, Socci C, Kaiser N, Gross DJ, et al.: Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes 1999, 48:1230-1236. Human islets were cultured as monolayers on extracellular matrix; 4-to 9-day exposure to 33 mM glucose reduced islet insulin stores, insulin mRNA, insulin gene transcription, and the DNA-binding and mRNA levels of PDX-1, with no or minor changes in RIPE3b1 Act or IEF1. It is suggested that downregulation of PDX-1 plays a key role in glucose toxicity.
9. 9 Kaiser N, Corcos AP, Tur-Sinai A, Ariav Y, Cerasi E: Monolayer culture of adult pancreatic islets on extracellular matrix: long-term maintenance of differentiated B-cell function. Endocrinology 1988, 123:834-840.
10. 10 Kaiser N, Corcos AP, Sarel I, Cerasi E: Monolayer culture of adult rat pancreatic islets on extracellular matrix: modulation of B-cell function by chronic exposure to high glucose. Endocrinology 1991, 129:2067-2076.
11. 11 Hou X, Ling Z, Quartier E, Foriers A, Schuit F, Pipeleers D, Van Schravendijk C: Prolonged exposure of pancreatic beta cells to raised glucose concentrations results in increased cellular content of islet amyloid polypeptide precursors. Diabetologia 1999, 42:188-194. This study shows that 6-day stimulation with high glucose reduces the insulin, but not islet amyloid polypeptide (IAPP) content of human islets; yet the proportion of IAPP precursors increases in a fashion similar to proinsulin.
12. 12 Usac EF, Nadal B, Gasa R, Fernandez-Alvarez J, Gomis R: Effect of high glucose concentration on proinsulin biosynthesis and conversion by human islets. Biochem Biophys Res Commun 1998, 248:186-189.
13. 13 Zambre Y, Ling Z, Hou X, Foriers A, Van Den Bogaert B, Van Schravendijk C, Pipeleers D: Effect of glucose on production and release of proinsulin conversion products by cultured human islets. J Clin Endocrinol Metab 1998, 83:1234-1238.
14. 14 German M, Ashcroft S, Docherty K, Edlund H, Edlund T, Goodison S, et al.: The insulin gene promoter. A simplified nomenclature [letter]. Diabetes 1995, 44:1002-1004.
15. 15 Dumonteil E, Philippe J: Insulin gene: organisation, expression and regulation. Diabetes Metab 1996, 22:164-173.
16. 16 Jonsson J, Carlsson L, Edlund T, Edlund H: Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994, 371:606-609.
17. 17 Ohlsson H, Karlsson K, Edlund T: IPF1, a homeodomain-containing transactivator of the insulin gene. Embo J 1993, 12:4251-4259.
18. 18 Melloul D, Ben-Neriah Y, Cerasi E: Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoters. Proc Natl Acad Sci USA 1993, 90:3865-3869.
19. 19 Marshak S, Totary H, Cerasi E, Melloul D: Purification of the beta-cell glucose-sensitive factor that transactivates the insulin gene differentially in normal and transformed islet cells. Proc Natl Acad Sci USA 1996, 93:15057-15062.
20. 20 Hwung YP, Gu YZ, Tsai MJ: Cooperativity of sequence elements mediates tissue specificity of the rat insulin II gene. Mol Cell Biol 1990, 10:1784-1788.
21. 21 Sharma A, Fusco-DeMane D, Henderson E, Efrat S, Stein R: The role of the insulin control element and RIPE3b1 activators in glucose-stimulated transcription of the insulin gene. Mol Endocrinol 1995, 9:1468-1476.
22. 22 Walker MD, Park CW, Rosen A, Aronheim A: A cDNA from a mouse pancreatic beta cell encoding a putative transcription factor of the insulin gene. Nucleic Acids Res 1990, 18:1159-1166.
23. 23 German MS, Blanar MA, Nelson C, Moss LG, Rutter WJ: Two related helix-loop-helix proteins participate in separate cell-specific complexes that bind the insulin enhancer. Mol Endocrinol 1991, 5:292-299.
24. 24 Naya FJ, Huang HP, Qiu Y, Mutoh H, DeMayo FJ, Leiter AB, Tsai MJ: Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev 1997, 11:2323-2334.
25. 25 Naya FJ, Stellrecht CM, Tsai MJ: Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes Dev 1995, 9:1009-1019.
26. 26 Seufert J, Kieffer TJ, Leech CA, Holz GG, Moritz W, Ricordi C, Habener JF: Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellius. J Clin Endocrinol Metab 1999, 84:670-676.
27. 27 Poitout V, Olson LK, Robertson RP: Chronic exposure of βTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator. J Clin Invest 1996, 97:1041-1046.
28. 28 Zangen DH, Bonner-Weir S, Lee CH, Latimer JB, Miller CP, Habener JF, Weir GC: Reduced insulin, GLUT2, and IDX-1 in beta-cells after partial pancreatectomy. Diabetes 1997, 46:258-264.
29. 29 Harmon JS, Gleason CE, Tanaka Y, Oseid EA, Hunter-Berger KK, Robertson RP: In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression. Diabetes 1999, 48:1995-2000. Chronic hyperglycemia in ZDF rats is associated with loss of insulin and PDX-1 mRNAs and loss of glucose-stimulated insulin secretion. Prevention of hyperglycemia with troglitazone prevented these defects.
30. 30 Jonas JC, Sharma A, Hasenkamp W, Ilkova H, Patane G, Laybutt R, et al.: Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J Biol Chem 1999, 274:14112-14121. In 90% pancreatectomized hyperglycemic rats, the expression of many genes important for glucose-induced insulin release decreased with increasing hyperglycemia, in parallel with reduction in several islet transcription factors involved in β-cell development and differentiation.
31. 31 Tajiri Y, Moller C, Grill V: Long-term effects of aminoguanidine on insulin release and biosynthesis: evidence that the formation of advanced glycosylation end products inhibits B cell function. Endocrinology 1997, 138:273-280.
32. 32 Matsuoka T, Kajimoto Y, Watada H, Kaneto H, Kishimoto M, Umayahara Y, et al.: Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest 1997, 99:144-150.
33. 33 Ihara Y, Toyokuni S, Uchida K, Odaka H, Tanaka T, Ikeda H, et al.: Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes 1999, 48:927-932. The level of 8-hydroxy-2′-deoxyguanosine, a marker of oxidative stress, was increased in the β-cells of GK rats, a model of nonobese type 2 diabetes.
34. 34 Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP: Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci USA 1999, 96:10857-10862. Administration of the antioxidants N-acetyl-L-cysterine or aminoguanidine to Zucker diabetic fatty rats prevented rise in blood oxidative stress markers, and partially prevented hyperglycemia and the associated defects in insulin secretion and biosynthesis.